MA28539B1 - Imidazoles nouveaux - Google Patents

Imidazoles nouveaux

Info

Publication number: MA28539B1
Authority: MA; Morocco
Prior art keywords: new imidazoles; imidazoles; new
Prior art date: 2004-04-16

Application number

MA29394A

Other languages

English (en)

Inventor

Gary Louis Bolton

Daniel Merritt Bowles

David Christopher Boyles

Walter Allen Howard Jr

Richard Henry Hutchings

Robert Michael Kennedy

William Keun-Chan Park

Yuntao Song

Bharat Kalidas Trivedi

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-16

Filing date

2006-10-16

Publication date

2007-04-03

2006-10-16 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2007-04-03 Publication of MA28539B1 publication Critical patent/MA28539B1/fr

Links

150000002460 imidazoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

MA29394A 2004-04-16 2006-10-16 Imidazoles nouveaux MA28539B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US56312404P	2004-04-16	2004-04-16
US60070504P	2004-08-11	2004-08-11

Publications (1)

Publication Number	Publication Date
MA28539B1 true MA28539B1 (fr)	2007-04-03

Family

ID=35242215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29394A MA28539B1 (fr)	2004-04-16	2006-10-16	Imidazoles nouveaux

Country Status (23)

Country	Link
US (2)	US20050239857A1 (fr)
EP (1)	EP1740549A2 (fr)
JP (1)	JP2007532653A (fr)
KR (1)	KR20060133013A (fr)
AP (1)	AP2006003766A0 (fr)
AR (1)	AR049023A1 (fr)
AU (1)	AU2005237428A1 (fr)
BR (1)	BRPI0509926A (fr)
CA (1)	CA2563222A1 (fr)
CR (1)	CR8687A (fr)
EA (1)	EA200601678A1 (fr)
EC (1)	ECSP066931A (fr)
IL (1)	IL178208A0 (fr)
MA (1)	MA28539B1 (fr)
MX (1)	MXPA06011657A (fr)
NO (1)	NO20065231L (fr)
NZ (1)	NZ550061A (fr)
PA (1)	PA8630801A1 (fr)
PE (1)	PE20060184A1 (fr)
SV (1)	SV2006002089A (fr)
TW (1)	TW200538442A (fr)
UY (1)	UY28856A1 (fr)
WO (1)	WO2005105079A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2328384T3 (es)	2004-11-23	2009-11-12	Warner-Lambert Company Llc	Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
WO2007042910A1 (fr) *	2005-10-14	2007-04-19	Pfizer Products Inc.	IMIDAZOLES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA HMG-CoA-RÉDUCTASE
WO2007049121A1 (fr) *	2005-10-28	2007-05-03	Pfizer Products Inc.	Forme cristalline de sodium ; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate
US20090227602A1 (en) *	2005-10-28	2009-09-10	John Griffin	Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
WO2007107843A1 (fr) *	2006-03-22	2007-09-27	Pfizer Products Inc.	Procédés de traitement avec des inhibiteurs de la cetp
WO2008038098A1 (fr) *	2006-09-25	2008-04-03	Pfizer Products Inc.	Forme cristalline de l'acide 7[5-cyclopropyl)-4-o-fluorobenzylcarbamoyl)-2-(4-fluorophényl)-imidazol-1-yl]-3r,5r-dihydroxyheptanoïque
DE102007051339A1 (de) *	2007-10-26	2009-04-30	Müller-Enoch, Dieter, Prof. Dr.	Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
DE102010012235A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Imidazole
DE102010012232A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Irnidazole
DE102010012233A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Imidazole
WO2026006786A1 (fr) *	2024-06-28	2026-01-02	Osanni Bio, Inc.	Composé, compositions et méthodes d'utilisation associées

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4755606A (en) *	1985-05-22	1988-07-05	Sandoz Pharm. Corp.	Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates
US4808607A (en) *	1985-05-22	1989-02-28	Sandoz Pharm. Corp.	Imidazole analogs of mevalonolactone and derivatives thereof for use in inhibiting cholesterol biosynthesis and lowering blood cholesterol level
US4681893A (en) *	1986-05-30	1987-07-21	Warner-Lambert Company	Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5013749A (en) *	1988-10-03	1991-05-07	Glaxo Group Limited	Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents
FI94339C (fi) *	1989-07-21	1995-08-25	Warner Lambert Co	Menetelmä farmaseuttisesti käyttökelpoisen /R-(R,R)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5252322A (en) *	1989-09-22	1993-10-12	The Gillette Company	Skin tanning compositions containing imidazoles
BR9609872A (pt) *	1995-07-17	1999-03-23	Warner Lambert Co	Hemi sal de cálcio de ácido (R-(RR)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino
US5705145A (en) *	1996-08-21	1998-01-06	E-L Management Corp.	Skin tanning compositions and method
KR100538958B1 (ko) *	1999-09-20	2005-12-26	닛뽕소다 가부시키가이샤	4(5)-아미노-5(4)-카르복사미도이미다졸 및 그의 중간체의 제조방법

2005
- 2005-04-12 KR KR1020067021283A patent/KR20060133013A/ko not_active Ceased
- 2005-04-12 NZ NZ550061A patent/NZ550061A/en unknown
- 2005-04-12 AU AU2005237428A patent/AU2005237428A1/en not_active Abandoned
- 2005-04-12 MX MXPA06011657A patent/MXPA06011657A/es not_active Application Discontinuation
- 2005-04-12 WO PCT/US2005/012255 patent/WO2005105079A2/fr not_active Ceased
- 2005-04-12 AP AP2006003766A patent/AP2006003766A0/xx unknown
- 2005-04-12 JP JP2007508439A patent/JP2007532653A/ja not_active Ceased
- 2005-04-12 CA CA002563222A patent/CA2563222A1/fr not_active Abandoned
- 2005-04-12 EP EP05733869A patent/EP1740549A2/fr not_active Withdrawn
- 2005-04-12 EA EA200601678A patent/EA200601678A1/ru unknown
- 2005-04-12 BR BRPI0509926-9A patent/BRPI0509926A/pt not_active IP Right Cessation
- 2005-04-13 US US11/105,288 patent/US20050239857A1/en not_active Abandoned
- 2005-04-13 TW TW094111697A patent/TW200538442A/zh unknown
- 2005-04-15 PE PE2005000420A patent/PE20060184A1/es not_active Application Discontinuation
- 2005-04-15 SV SV2005002089A patent/SV2006002089A/es not_active Application Discontinuation
- 2005-04-15 PA PA20058630801A patent/PA8630801A1/es unknown
- 2005-04-15 UY UY28856A patent/UY28856A1/es not_active Application Discontinuation
- 2005-04-15 AR ARP050101510A patent/AR049023A1/es unknown
2006
- 2006-03-24 US US11/389,664 patent/US20060287378A1/en not_active Abandoned
- 2006-09-20 IL IL178208A patent/IL178208A0/en unknown
- 2006-10-12 CR CR8687A patent/CR8687A/es not_active Application Discontinuation
- 2006-10-16 EC EC2006006931A patent/ECSP066931A/es unknown
- 2006-10-16 MA MA29394A patent/MA28539B1/fr unknown
- 2006-11-14 NO NO20065231A patent/NO20065231L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP066931A (es)	2006-12-20
JP2007532653A (ja)	2007-11-15
NZ550061A (en)	2009-05-31
TW200538442A (en)	2005-12-01
CA2563222A1 (fr)	2005-11-10
AP2006003766A0 (en)	2006-10-31
EP1740549A2 (fr)	2007-01-10
IL178208A0 (en)	2006-12-31
EA200601678A1 (ru)	2007-04-27
PE20060184A1 (es)	2006-04-22
UY28856A1 (es)	2005-11-30
NO20065231L (no)	2007-01-09
US20060287378A1 (en)	2006-12-21
PA8630801A1 (es)	2006-03-24
KR20060133013A (ko)	2006-12-22
CR8687A (es)	2007-06-29
AU2005237428A1 (en)	2005-11-10
WO2005105079A3 (fr)	2006-01-12
SV2006002089A (es)	2006-02-15
MXPA06011657A (es)	2007-04-23
BRPI0509926A (pt)	2007-09-18
US20050239857A1 (en)	2005-10-27
AR049023A1 (es)	2006-06-21
WO2005105079A2 (fr)	2005-11-10

Publication	Publication Date	Title
MA28929B1 (fr)	2007-10-01	Nouveaux insecticides
ATE533490T1 (de)	2011-12-15	4-phenylamino-chinazolin-6-yl-amide
MA28933B1 (fr)	2007-10-01	Nouveaux composes
EP1788835A4 (fr)	2010-11-24	Système de haut-parleur
DE602005002247D1 (de)	2007-10-11	Lautsprecher
DE602005006955D1 (de)	2008-07-03	Klopferkennung
ATE520680T1 (de)	2011-09-15	Hiv-hemmende 5-heterocyclylpyrimidine
ATE392425T1 (de)	2008-05-15	Thiazolyl-dihydro-indazole
DK1779007T3 (da)	2014-01-27	Komposit-drejetætningsindretning
ATE459633T1 (de)	2010-03-15	Makrolide
DE602005024018D1 (de)	2010-11-18	Lautsprecher
DE502005008587D1 (de)	2010-01-07	Kugelgelenk
DE602005003649D1 (de)	2008-01-17	Hydraulikhammer
EP1696697A4 (fr)	2010-10-06	Haut-parleur
DK1853582T3 (da)	2010-01-18	Heterocyclylamid-substituerede imidazoler
AT500198B1 (de)	2006-09-15	Ladewagen
DE202005000325U1 (de)	2005-03-24	Lautsprecher
ATE389633T1 (de)	2008-04-15	Omega-phenyloctanamide
AT500249A3 (de)	2006-03-15	Scheibenegge
NO20044198L (no)	2006-04-03	Mikrofon
FR2869760B1 (fr)	2008-06-13	Cornadis
ATA482004A (de)	2005-07-15	Tuba-dämpfer
AT7802U3 (de)	2007-11-15	Parfum-zerstäuber
ATA9982004A (de)	2005-07-15	Tiefbohrbrunnen
ATA6902004A (de)	2005-02-15	Polstermöbel